David Kleiner

David Kleiner

National Cancer Institute - Bethesda / United States
Medical and Health Sciences / Medical Biochemistry
AD Scientific Index ID: 4394017
person_outline David Kleiner's MOST POPULAR ARTICLES
1-) Design and validation of a histological scoring system for nonalcoholic fatty liver diseaseDE Kleiner, EM Brunt, M Van Natta, C Behling, MJ Contos, OW Cummings, ...Hepatology 41 (6), 1313-1321, 200590032005
2-) Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitisAJ Sanyal, N Chalasani, KV Kowdley, A McCullough, AM Diehl, NM Bass, ...New England Journal of Medicine 362 (18), 1675-1685, 201032352010
3-) Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver diseaseP Angulo, DE Kleiner, S Dam-Larsen, LA Adams, ES Bjornsson, ...Gastroenterology 149 (2), 389-397. e10, 201521842015
4-) MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver diseaseM Eslam, AJ Sanyal, J George, A Sanyal, B Neuschwander-Tetri, ...Gastroenterology 158 (7), 1999-2014. e1, 202028672020
5-) Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trialBA Neuschwander-Tetri, R Loomba, AJ Sanyal, JE Lavine, ML Van Natta, ...The Lancet 385 (9972), 956-965, 201525002015